Department of Intensive Care, Austin Hospital, Melbourne, Australia; Division of Nephrology, Department of Medicine, National University Hospital, National University Health System, Singapore.
Department of Intensive Care, Austin Hospital, Melbourne, Australia; Department of Intensive Care, Centre Hospitalo-Universitaire Vaudois, Lausanne, Switzerland.
Am J Kidney Dis. 2014 Dec;64(6):909-17. doi: 10.1053/j.ajkd.2014.04.022. Epub 2014 Jun 2.
The risk of catheter-related infection or bacteremia, with initial and extended use of femoral versus nonfemoral sites for double-lumen vascular catheters (DLVCs) during continuous renal replacement therapy (CRRT), is unclear.
Retrospective observational cohort study.
SETTING & PARTICIPANTS: Critically ill patients on CRRT in a combined intensive care unit of a tertiary institution.
Femoral versus nonfemoral venous DLVC placement.
Catheter-related colonization (CRCOL) and bloodstream infection (CRBSI).
CRCOL/CRBSI rates expressed per 1,000 catheter-days.
We studied 458 patients (median age, 65 years; 60% males) and 647 DLVCs. Of 405 single-site only DLVC users, 82% versus 18% received exclusively 419 femoral versus 82 jugular or subclavian DLVCs, respectively. The corresponding DLVC indwelling duration was 6±4 versus 7±5 days (P=0.03). Corresponding CRCOL and CRBSI rates (per 1,000 catheter-days) were 9.7 versus 8.8 events (P=0.8) and 1.2 versus 3.5 events (P=0.3), respectively. Overall, 96 patients with extended CRRT received femoral-site insertion first with subsequent site change, including 53 femoral guidewire exchanges, 53 new femoral venipunctures, and 47 new jugular/subclavian sites. CRCOL and CRBSI rates were similar for all such approaches (P=0.7 and P=0.9, respectively). On multivariate analysis, CRCOL risk was higher in patients older than 65 years and weighing >90kg (ORs of 2.1 and 2.2, respectively; P<0.05). This association between higher weight and greater CRCOL risk was significant for femoral DLVCs, but not for nonfemoral sites. Other covariates, including initial or specific DLVC site, guidewire exchange versus new venipuncture, and primary versus secondary DLVC placement, did not significantly affect CRCOL rates.
Nonrandomized retrospective design and single-center evaluation.
CRCOL and CRBSI rates in patients on CRRT are low and not influenced significantly by initial or serial femoral catheterizations with guidewire exchange or new venipuncture. CRCOL risk is higher in older and heavier patients, the latter especially so with femoral sites.
在连续性肾脏替代治疗(CRRT)期间,使用股静脉与非股静脉部位进行双腔血管导管(DLVC)置管时,导管相关感染或菌血症的风险,初始和延长使用时的情况尚不清楚。
回顾性观察队列研究。
在一家三级机构的综合重症监护病房中接受 CRRT 的危重症患者。
股静脉与非股静脉 DLVC 置管。
导管相关性定植(CRCOL)和血流感染(CRBSI)。
每 1000 个导管日表示的导管相关感染(CRCOL)/血流感染(CRBSI)率。
我们研究了 458 名患者(中位年龄 65 岁;60%为男性)和 647 个 DLVC。在 405 名仅使用单部位的 DLVC 使用者中,82%接受了 419 个股静脉 DLVC,18%接受了 82 个颈内静脉或锁骨下静脉 DLVC,分别为 82%和 18%。相应的 DLVC 留置时间为 6±4 天与 7±5 天(P=0.03)。相应的 CRCOL 和 CRBSI 发生率(每 1000 个导管日)分别为 9.7 比 8.8 事件(P=0.8)和 1.2 比 3.5 事件(P=0.3)。总体而言,96 名接受延长 CRRT 的患者首先接受了股静脉部位的插入,随后进行了部位更换,包括 53 例股静脉导丝交换、53 例新的股静脉穿刺和 47 例新的颈内静脉/锁骨下静脉部位。所有这些方法的 CRCOL 和 CRBSI 发生率相似(P=0.7 和 P=0.9)。多变量分析显示,年龄>65 岁和体重>90kg 的患者 CRCOL 风险更高(比值比分别为 2.1 和 2.2;P<0.05)。这种与较高体重和更高 CRCOL 风险之间的关联在股静脉 DLVC 中很明显,但在非股静脉部位则不然。其他协变量,包括初始或特定 DLVC 部位、导丝交换与新的静脉穿刺,以及原发性与继发性 DLVC 置管,并未显著影响 CRCOL 发生率。
非随机回顾性设计和单中心评估。
在接受 CRRT 的患者中,CRCOL 和 CRBSI 发生率较低,初始或连续股静脉置管时,导丝交换或新的静脉穿刺并不会显著影响其发生率。年龄较大和体重较重的患者 CRCOL 风险更高,尤其是股静脉部位。